2025-08872NoticeWallet

FDA Starts Reworking the Fees Behind Generic Drug Approvals

Published Date: 5/19/2025

Notice

Summary

The FDA is gearing up to renew the Generic Drug User Fee program for 2028-2032, which helps fund faster approval of generic medicines. They’re hosting a public meeting on July 11, 2025, and want your ideas on how to improve the program before collecting fees again. If you’re involved in making or using generic drugs, this is your chance to shape the future—and don’t forget to send your comments by August 11, 2025!

Analyzed Economic Effects

2 provisions identified: 1 benefits, 1 costs, 0 mixed.

Generic drug makers must pay user fees

If you make or submit generic drug applications, the FDA's GDUFA program requires that generic drug manufacturers and related entities pay user fees for certain generic drug applications, drug master files, and facilities. FDA is seeking reauthorization to collect these fees for fiscal years 2028 through 2032, and new legislation will be required by the end of September 2027 for fee collection to continue.

User fees fund faster generic drug access

You may get faster access to generic medicines because FDA says the GDUFA program uses collected user fees to finance program enhancements aimed at reducing the number of assessment cycles for abbreviated new drug applications and to foster development and approval of complex generic products. These enhancements are intended to facilitate timely access to safe and effective generic drugs for the public.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
5/19/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register